Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay.

MLA

Schmidt, Stefan, et al. “Label-Free Assessment of Complement-Dependent Cytotoxicity of Therapeutic Antibodies via a Whole-Cell MALDI Mass Spectrometry Bioassay.” Scientific Reports, vol. 14, no. 1, Sept. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-024-71483-3.

APA

Schmidt, S., Geisel, A., Enzlein, T., Fröhlich, B. C., Pritchett, L., Verneret, M., Graf, C., & Hopf, C. (2024). Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay. Scientific Reports, 14(1), 1–11. https://doi.org/10.1038/s41598-024-71483-3

Chicago

Schmidt, Stefan, Alexander Geisel, Thomas Enzlein, Björn C. Fröhlich, Louise Pritchett, Melanie Verneret, Christian Graf, and Carsten Hopf. 2024. “Label-Free Assessment of Complement-Dependent Cytotoxicity of Therapeutic Antibodies via a Whole-Cell MALDI Mass Spectrometry Bioassay.” Scientific Reports 14 (1): 1–11. doi:10.1038/s41598-024-71483-3.